+91- 99099 19545
info@accuprec.com
World Quality Congress organised the Quality Healthcare Awards, a premier award program to recognize and reward the outstanding accomplishments in Quality, on 4th July 2019 at Mumbai. Veeda Clinical Research was bestowed as the "Best Quality Clinical Research Organisation in...
Read More
3rd convocation of National Institute of Pharmaceutical Education and Research, Guwahati (NIPER-Guwahati) was held with a day-long program at the Institute of Advanced Study in Science & Technology (IASST) auditorium of Guwahati. In his welcome address, Dr URN Murthy, the...
Read More
Shalby Hospitals awarded for Best Brand Evolution Award 2019 category under Healthcare Excellence Award by Indian Express. Dr. Bharat Gajjar from Shalby Hospitals accepted the award. Speaking on the occasion, Dr. Gajjar said that this award reflects trust put by...
Read More
A one-day workshop on regulatory systems in the pharma sector,was jointly organized by National Medical Products Administration (NMPA, erstwhile CFDA) and Central Drugs Standard Control Organisation (CDSCO) for the benefit of Indian pharmaceutical companies on 21st June, 2019 in Shanghai,...
Read More A discovery from the University of Calgary is attracting world-wide attention because it could change how we do surgery and how we heal the heart. Su-Ling Goh explains. University of Calgary researchers say a newly discovered type of cell appears...
Read More The Bill including separate legislative provisions for medical devices called as the Drugs and Cosmetics (Amendment) Bill was introduced in the Rajya Sabha on 29.08.2013 which was referred to the Standing Committee of Parliament. The Standing Committee made certain recommendations...
Read More Delhi High Court dismissed a petition filed by Themis Medicare challenging the ban imposed by the Drug Controller General of India (DCGI) on Diclofenac injection 75 mg/1ml marketed by its partner Novartis under Voveran 1ml brand. Diclofenac is used in...
Read More Cipla (EU) Limited, a U.K.- based wholly-owned subsidiary of the leading global ph Cipla (EU) Limited and Jiangsu Acebright Pharmaceutical Co. Ltd. (“Acebright”) announced that they have entered into an agreement to set up a joint venture company (“JV Co”)...
Read More Pfizer Inc said on Friday that the U.S. Food and Drug Administration had approved its biosimilar to Roche Holding AG's blockbuster cancer treatment Avastin. Pfizer Inc said that the U.S. Food and Drug Administration had approved its biosimilar to Roche...
Read More Union Cabinet chaired by Prime Minister Narendra Modi has approved the following decisions: Modifying the earlier decision dated 28.12.2016 of sale of land of PSUs to government agencies and instead permitting the sale of land as per revised DPE's guidelines...
Read More Dr Harsh Vardhan, Union Minister of Health and Family Welfare today stressed on the importance of community participation for prevention and control of Vector Borne Diseases (VBDs) like Malaria, Dengue and Chikungunya as he began the three–day Jan Jagrukta Abhiyaan...
Read More The Union Cabinet chaired by Prime Minister Narendra Modi has given ex-post facto approval to the Inter-Institutional Agreement between India and the USA in the areas of regenerative medicine and 3D bioprinting, new technologies, exchange of scientific ideas/information and technologies,...
Read MoreGovernment has issued an advisory on 2nd April 2019 regarding scientific studies and publication of research papers on AYUSH drugs and treatments by Non-AYUSH Researchers/Scientists. This advisory has been issued in response to some reports published by non-AYUSH scientists/researchers with...
Read More Govt. plans to use AI for various issues in TB
Read More Zydus Cadila, an innovation-driven, global pharmaceutical company, announced that it has completed enrollment in EVIDENCES II, EVIDENCES III and EVIDENCES V Phase 3 clinical trials of Saroglitazar Mg for treating Non-Alcoholic SteatoHepatitis (NASH). Patients with NASH have been enrolled in...
Read More
Accuprec Research Labs Pvt. Ltd. © 2024
